secwatch / observer
8-K filed May 11, 2026, 7:59 PM ET ticker HAIN CIK 0000910406
earnings confidence low sentiment neutral materiality 0.50

Hain Celestial reports Q3 FY2026 earnings; detailed figures not included in filing excerpt

HAIN CELESTIAL GROUP INC

2026-Q3 EPS reported -$2.68 revenue$1,090,360,000
item 2.02item 9.01

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001193125-26-215679
form_type
8-K
ticker
HAIN
cik
0000910406
company_name
HAIN CELESTIAL GROUP INC
filed_at
2026-05-11T23:59:59+00:00
discovered_at
2026-05-14T18:02:33.919097+00:00
generated_at
2026-05-14T19:24:45.274531+00:00
sec_items
["2.02", "9.01"]
event_type
earnings
sentiment
neutral
materiality_score
0.5
calibrated_materiality_score
0.5
confidence
low
secwatch_canonical_url
https://secwatch.observer/filing/0001193125-26-215679
json_url
https://secwatch.observer/filing/0001193125-26-215679.json
markdown_url
https://secwatch.observer/filing/0001193125-26-215679.md
text_url
https://secwatch.observer/filing/0001193125-26-215679.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/910406/000119312526215679/0001193125-26-215679-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/910406/000119312526215679/hain-20260511.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Source-grounded claims

d55e39be8278d931f65b2440eb7f2879b310291e

HAIN CELESTIAL GROUP INC reported financial results for third quarter ended March 31, 2026.

On May 11, 2026, The Hain Celestial Group, Inc. (the “Company”) issued a press release announcing financial results for its third quarter ended March 31, 2026.

SEC 8-K Item 2.02 confidence 0.7 SEC evidence

Comparable filings

EXPI

eXp World Holdings Q1 revenue $1.0B (+5% YoY), net loss narrows to $(5.1M), Adj. EBITDA $4.1M (+88%)

eXp World Holdings, Inc. May 11, 2026, 7:59 PM ET earnings Items 2.02, 7.01, 9.01

same fact type: earnings_release same SEC item: 2.02, 9.01 same event type: earnings similar materiality

This filing

On May 11, 2026, The Hain Celestial Group, Inc. (the “Company”) issued a press release announcing financial results for its third quarter ended March 31, 2026.

Comparable filing

the company's scale and our focus on operational efficiency across eXp World Holdings,” said Jesse Hill, Chief Financial Officer of eXp World Holdings. “We generated revenue of $1.0 billion and Adjusted EBITDA of $4.1 million, an 88% improvement that further strengthened our financial position. More recently, we executed the strategic NextHome acquisition using cash

Filing page SEC filing

HRTX

Heron Q1 net revenue $34.7M (-10.8% YoY); Acute Care up 32%; guidance reaffirmed

HERON THERAPEUTICS, INC. /DE/ May 11, 2026, 7:59 PM ET earnings Items 2.02, 9.01

same fact type: earnings_release same SEC item: 2.02, 9.01 same event type: earnings similar materiality

This filing

On May 11, 2026, The Hain Celestial Group, Inc. (the “Company”) issued a press release announcing financial results for its third quarter ended March 31, 2026.

Comparable filing

Reaffirms Guidance - Q1 2026 net revenue growth year-over year for Acute Care franchise (+32%), including ZYNRELEF ® (+27%) and APONVIE ® (+50%) - Q1 2026 total net revenue of $34.7 million - Reached settlement with Baxter Healthcare Corporation in CINVANTI ® patent litigation - Reaffirmed 2026 full-year guidance of $173–$183 million net revenue; $10–$20 million

Filing page SEC filing

XGN

Exagen Q1 2026: Record revenue $17.3M, net loss $4.0M; FY guidance reaffirmed

EXAGEN INC. May 11, 2026, 7:59 PM ET earnings Items 2.02, 9.01

same fact type: earnings_release same SEC item: 2.02, 9.01 same event type: earnings similar materiality

This filing

On May 11, 2026, The Hain Celestial Group, Inc. (the “Company”) issued a press release announcing financial results for its third quarter ended March 31, 2026.

Comparable filing

Trailing-twelve-month average selling price (ASP) $ 444 $ 419 Cash and cash equivalents $ 21,513 $ 11,194 First Quarter 2026 Highlights: • Achieved record total revenue of $17.3 million, an increase of 12% compared to first quarter 2025. • Grew AVISE CTD test volume 10% compared to first quarter 2025. • Expanded AVISE CTD trailing-twelve-month ASP to $444 per

Filing page SEC filing

CGBD

Carlyle Secured Lending Q1 NII $0.36/sh; NAV down 2.3% to $15.89; declares $0.35 dividend

Carlyle Secured Lending, Inc. May 11, 2026, 7:59 PM ET earnings Items 2.02, 7.01, 9.01

same fact type: earnings_release same SEC item: 2.02, 9.01 same event type: earnings similar materiality

This filing

On May 11, 2026, The Hain Celestial Group, Inc. (the “Company”) issued a press release announcing financial results for its third quarter ended March 31, 2026.

Comparable filing

For the first quarter of 2026, we reported $0.36 per common share of Net Investment Income and Adjusted Net Investment Income, a non-GAAP financial measure described below.

Filing page SEC filing

OPAL

OPAL Fuels Q1 2026 Adj EBITDA $16.7M, net loss $(5.6)M; revenue down 14% YoY

OPAL Fuels Inc. May 11, 2026, 7:59 PM ET earnings Items 2.02, 9.01

same fact type: earnings_release same SEC item: 2.02, 9.01 same event type: earnings similar materiality

This filing

On May 11, 2026, The Hain Celestial Group, Inc. (the “Company”) issued a press release announcing financial results for its third quarter ended March 31, 2026.

Comparable filing

Revenue for the three months ended March 31, 2026 and 2025, was $73.4 million and $85.4 million respectively, a decrease of (14)%, compared to the same period last year. 1 • Net (loss) income for the three months ended March 31, 2026 was $(5.6) million, compared to $1.3 million in the same period last year. • Basic and diluted net loss per share attributable to Class A common shareholders for the three months ended months ended March 31, 2026 were $(0.09) compared to $(0.01) in the comparable period last year.

Filing page SEC filing

OLPX

Olaplex Q1 net sales up 2.5% to $99.4M but swings to net loss of $5.3M; adjusted EBITDA falls 26.1%

OLAPLEX HOLDINGS, INC. May 11, 2026, 7:59 PM ET earnings Items 2.02, 9.01

same fact type: earnings_release same SEC item: 2.02, 9.01 same event type: earnings similar materiality

This filing

On May 11, 2026, The Hain Celestial Group, Inc. (the “Company”) issued a press release announcing financial results for its third quarter ended March 31, 2026.

Comparable filing

team for their continued dedication and commitment to our transformation." For the first quarter of 2026 compared to the first quarter of 2025: • Net sal es increased 2.5% to $99.4 million; ◦ By channel: ▪ Specialty Retail decreased 13.3% to $33.4 million; ▪ Professional increased 12.3% to $38.8 million; ▪ Direct-To-Consumer increased 13.8% to $27.2 million; ◦ Net

Filing page SEC filing

FEMY

Femasys reports Q1 net income of $846K; sales up 24.5%; cash sufficient into Q3 2026

FEMASYS INC May 8, 2026, 7:59 PM ET earnings Items 2.02, 9.01

same fact type: earnings_release same SEC item: 2.02, 9.01 same event type: earnings similar materiality

This filing

On May 11, 2026, The Hain Celestial Group, Inc. (the “Company”) issued a press release announcing financial results for its third quarter ended March 31, 2026.

Comparable filing

addressing critical unmet needs with safe, technologically advanced products.” Financial Results for Quarter Ended March 31, 2026 • Sales increased by $83,625, or 24.5%, to $424,889 in 2026 from $341,264 in 2025, primarily due to sales of FemBloc. • Research and development expenses decreased by $1,659,071, or 55.9%, to $1,309,401 in 2026 compared to

Filing page SEC filing

ENTXW

Entera Bio Q1 net loss $3.5M; cash $20.4M; EB613 Phase 3 protocol submitted to FDA

Entera Bio Ltd. May 8, 2026, 7:59 PM ET earnings Items 2.02, 7.01, 9.01

same fact type: earnings_release same SEC item: 2.02, 9.01 same event type: earnings similar materiality

This filing

On May 11, 2026, The Hain Celestial Group, Inc. (the “Company”) issued a press release announcing financial results for its third quarter ended March 31, 2026.

Comparable filing

Entera Bio Ltd. (NASDAQ: ENTX) ("Entera" or the "Company"), a leader in the development of oral peptides, today reported financial results and key business updates for the quarter ended March 31, 2026.

Filing page SEC filing

Source: SEC EDGAR
accession 0001193125-26-215679
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.